Trial Condition(s):

Overactive Bladder

Post Marketing Surveillance Study on Emselex after launch in Germany

Bayer Identifier:

12245

ClinicalTrials.gov Identifier:

NCT00786448

EudraCT Number:

Not Available

Study Completed

Trial Purpose

- Data are obtained of Emselex in routine treatment of Overactive Bladder. The general objectives are to evaluate the product safety, compatibility, efficacy and patient acceptance.

Inclusion Criteria
- Patients who are treated with Emselex for Overactive Bladder
Exclusion Criteria
- Exclusion criteria are the contraindications as specified in the German product information

Trial Summary

Enrollment Goal
5821
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Emselex (Darifenacin, BAY79-4998)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Germany

Status
Completed
 

Trial Design